Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OSU6162 for fatigue and neuropsychological sequelae after aneurysmal subarachnoid haemorrhage
2016-004739-19Phase 2Completed
- Sponsor
- Oslo University Hospital
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in subarachnoid hemorrhage (SAH) and Neuropsychological dysfunction after aneurysmal subarachnoid hemorrhage comparing OSU6162 with Placebo (2 arms). Primary endpoint: Global Clinical Impression of Change (CGI-C) improvement score. Started Feb 2017; status: completed.
02
Drugs
OSU-6162
03
Conditions
subarachnoid hemorrhage (SAH)Neuropsychological dysfunction after aneurysmal subarachnoid hemorrhage
Beyond the preview
Go deeper on 2016-004739-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004739-19.